chartexchange

XERS
Xeris Biopharma Holdings, Inc. Common Stock
stockNASDAQ

At CloseOct 2, 2026 4:00:01 PM EDT
9.09USD-1.730%(-0.16)1,803,575
Pre-marketOct 5, 2026 8:20:30 AM EDT
9.1217USD+0.459%(+0.0417)
After-hoursOct 2, 2026 4:09:30 PM EDT
9.126USD+0.396%(+0.036)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Chicago, IL, USA
Previous Close
$9.25
Beta
0.80
52-Week High
$11.33 2026-09-29
52-Week Low
$5.25 2026-03-25
SMA 50
$8.46
SMA 200
$7.20
Avg. Vol 10D
4.28M
Avg. Vol 30D
2.58M
Avg. Vol 90D
2.14M
Relative Vol
0.70
182.32M
164.66M
0.4100%
6,000,000
Nov 5, 2026 (31d)
XERS Profile

xeris aspires to break through this restraint by developing ultra-low volume, ready-to-use biotherapeutics delivered through patient-friendly injectable devices. products built on our xeriject technologies could potentially ease the pain of injections for hundreds of millions of patients.

XERS Performance
PeriodPriceDateChangeBeta
1W9.832026-09-28-7.38%-0.562
1M8.532026-09-04+6.74%1.411
3M8.372026-07-06+8.78%0.439
6M6.052026-04-06+50.50%0.477
1Y8.132025-10-06+11.99%0.803
2Y2.982024-10-04+205.54%—
5Y2.372021-10-05+284.18%1.203
XERS Stock Summary

Xeris Biopharma Holdings, Inc. Common Stock (NASDAQ:XERS) stock price today is $9.11, and today's volume is 1,803,575. XERS is down 1.568% today. The 30 day average volume is 2.58M. XERS market cap is $1.66B with 182.32M shares outstanding.